Top

Published in:

01-06-2014 | Original Article

Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy

Authors: Aslam Ejaz, Gaya Spolverato, Yuhree Kim, Donald L. Lucas, Brandyn Lau, Matthew Weiss, Fabian M. Johnston, Marian Kheng, Kenzo Hirose, Christopher L. Wolfgang, Elliott Haut, Timothy M. Pawlik

Published in: Journal of Gastrointestinal Surgery | Issue 6/2014

Abstract

Background

The incidence of venous thromboembolism (VTE) among patients undergoing hepatic surgery is poorly defined, leading to varied use of VTE prophylaxis among surgeons. We sought to define the incidence of VTE after liver surgery and identify risk factors associated with VTE.

Methods

Incidence of VTE and associated risk factors within 90 days of hepatic resection between 2006 and 2012 at a major academic center was analyzed. Risk factors for VTE were identified using univariate and multivariate analyses.

Results

A total of 599 patients were included in the study cohort; 30 (5.0 %) had a prior history of VTE. The indications for surgery were malignant (90.8 %) and benign lesions (9.2 %). The majority of patients underwent a minor hepatectomy (<3 Couinaud segments; n = 402, 67.1 %) while 195 (32.6 %) patients underwent a major hepatectomy (≥3 Couinaud segments). Three hundred seven (51.3 %) patients were started on VTE chemoprophylaxis preoperatively with 407 (67.8 %) patients receiving VTE chemoprophylaxis within 24 h of surgery. Twenty-eight (4.7 %) patients developed VTE; 20 (3.3 %) had deep venous thrombosis (DVT), 11 (1.8 %) had pulmonary embolism (PE), and three (0.5 %) developed both DVT and PE. Among the VTE patients, 23 (82.1 %) had received VTE chemoprophylaxis. On multivariate analyses, history of VTE (odds ratio [OR] 4.51, 95 % confidence interval [CI] 1.81–17.22, P = 0.03), prolonged operative time (OR 1.17 per additional hour, 95 % CI 1.04–1.32, P = 0.009), and increased length of stay (LOS) (OR 1.07, 95 % CI 1.02–1.12, P = 0.01) were independent risk factors for VTE.

Conclusion

VTE within 90 days of hepatic resection is common, occurring in nearly one in 20 patients. Most VTE events occurred among patients who received current best practice prophylaxis for VTE. More aggressive strategies to identify and reduce the risk of VTE in patients at highest risk of VTE, including those with a history of VTE, extended operative time, and prolonged LOS, are warranted.

Collins, R., A. Scrimgeour, S. Yusuf and R. Peto, Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med, 1988. 318(18): p. 1162–73.PubMedCrossRef

Mismetti, P., S. Laporte, J.Y. Darmon, et al., Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg, 2001. 88(7): p. 913–30.PubMedCrossRef

Caprini, J.A., J.I. Arcelus, J.H. Hasty, et al., Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost, 1991. 17 Suppl 3: p. 304–12.PubMed

Gould, M.K., D.A. Garcia, S.M. Wren, et al., Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012. 141(2 Suppl): p. e227S–77S.PubMedCentralPubMed

Dindo, D., N. Demartines and P.A. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004. 240(2): p. 205–13.PubMedCentralPubMedCrossRef

Mayo, S.C., A.D. Shore, H. Nathan, et al., Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion. HPB (Oxford), 2011. 13(7): p. 473–82.CrossRef

Ho, Y.H., F. Seow-Choen, A. Leong, et al., Randomized, controlled trial of low molecular weight heparin vs. no deep vein thrombosis prophylaxis for major colon and rectal surgery in Asian patients. Dis Colon Rectum, 1999. 42(2): p. 196–202; discussion 202–3.PubMedCrossRef

De Martino, R.R., P.P. Goodney, E.L. Spangler, et al., Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg, 2012. 55(4): p. 1035–1040 e4.PubMedCentralPubMedCrossRef

Hyder, O., C. Pulitano, A. Firoozmand, et al., A risk model to predict 90-day mortality among patients undergoing hepatic resection. J Am Coll Surg, 2013. 216(6): p. 1049–56.PubMedCrossRef

10.

Sato, M., R. Tateishi, H. Yasunaga, et al., Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol, 2012. 47(10): p. 1125–33.PubMedCrossRef

11.

Bhayani, N.H., O. Hyder, W. Frederick, et al., Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis. Surgery, 2012. 152(2): p. 218–26.PubMedCentralPubMedCrossRef

12.

Jarnagin, W.R., M. Gonen, Y. Fong, et al., Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg, 2002. 236(4): p. 397–406; discussion 406–7.PubMedCentralPubMedCrossRef

13.

Turley, R.S., S.K. Reddy, C.K. Shortell, et al., Venous thromboembolism after hepatic resection: analysis of 5,706 patients. J Gastrointest Surg, 2012. 16(9): p. 1705–14.PubMedCrossRef

14.

Reddy, S.K., R.S. Turley, A.S. Barbas, et al., Post-operative pharmacologic thromboprophylaxis after major hepatectomy: does peripheral venous thromboembolism prevention outweigh bleeding risks? J Gastrointest Surg, 2011. 15(9): p. 1602–10.PubMedCrossRef

15.

Barton, J.S., G.M. Riha, J.A. Differding, et al., Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford), 2013.

16.

Cerutti, E., C. Stratta, R. Romagnoli, et al., Thromboelastogram monitoring in the perioperative period of hepatectomy for adult living liver donation. Liver Transpl, 2004. 10(2): p. 289–94.PubMedCrossRef

17.

Senzolo, M., M.T. Sartori and T. Lisman, Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford), 2009. 11(6): p. 459–64.CrossRef

18.

Salami, A., W. Qureshi, P. Kuriakose, et al. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review. Transplant Proc, 2013. 45(1): p. 315–9.PubMedCrossRef

19.

Aldawood, A., Y. Arabi, A. Aljumah, et al., The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J, 2011. 9(1): p. 1.PubMedCentralPubMedCrossRef

20.

Lesmana, C.R., S. Inggriani, L. Cahyadinata and L.A. Lesmana, Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int, 2010. 4(1): p. 433–8.PubMedCentralPubMedCrossRef

21.

Dabbagh, O., A. Oza, S. Prakash, et al., Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest, 2010. 137(5): p. 1145–9.PubMedCrossRef

22.

Barclay, S.M., M.N. Jeffres, K. Nguyen and T. Nguyen, Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease. Pharmacotherapy, 2013. 33(4): p. 375–82.PubMedCrossRef

23.

Tzeng, C.W., M.H. Katz, J.B. Fleming, et al., Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford), 2012. 14(8): p. 506–13.PubMedCentralCrossRef

24.

Merkow, R.P., K.Y. Bilimoria, M.D. McCarter, et al., Post-discharge venous thromboembolism after cancer surgery: extending the case for extended prophylaxis. Ann Surg, 2011. 254(1): p. 131–7.PubMedCrossRef

25.

Morris-Stiff, G., A. White, D. Gomez, et al., Thrombotic complications following liver resection for colorectal metastases are preventable. HPB (Oxford), 2008. 10(5): p. 311–4.CrossRef

26.

Hacker, R.I., G. Ritter, C. Nelson, et al., Subcutaneous heparin does not increase postoperative complications in neurosurgical patients: An institutional experience. J Crit Care, 2012. 27(3): p. 250–4.PubMedCrossRef

27.

Cohen, A.T., M.B. Wagner and M.S. Mohamed, Risk factors for bleeding in major abdominal surgery using heparin thromboprophylaxis. Am J Surg, 1997. 174(1): p. 1–5.PubMedCrossRef

28.

McLeod, R.S., W.H. Geerts, K.W. Sniderman, et al., Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial. Ann Surg, 2001. 233(3): p. 438–44.PubMedCentralPubMedCrossRef

29.

De, A., P. Roy, V.K. Garg and N.K. Pandey, Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinolysis, 2010. 21(1): p. 57–61.PubMedCrossRef

30.

Mita, K., H. Ito, R. Murabayashi, et al., Postoperative bleeding complications after gastric cancer surgery in patients receiving anticoagulation and/or antiplatelet agents. Ann Surg Oncol, 2012. 19(12): p. 3745–52.PubMedCrossRef

Title: Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy
Authors: Aslam Ejaz
Gaya Spolverato
Yuhree Kim
Donald L. Lucas
Brandyn Lau
Matthew Weiss
Fabian M. Johnston
Marian Kheng
Kenzo Hirose
Christopher L. Wolfgang
Elliott Haut
Timothy M. Pawlik
Publication date: 01-06-2014
Publisher: Springer US
Published in: Journal of Gastrointestinal Surgery / Issue 6/2014
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-013-2432-x

2024 ASCO Annual Meeting

Springer Medicine

Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy

Abstract

Background

Methods

Results

Conclusion

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2014

Analysis of Microscopic Tumor Spread Patterns According to Gross Morphologies and Suggestions for Optimal Resection Margins in Bile Duct Cancer

Surgical Outcome of Hilar Plate Resection: Extended Hilar Bile Duct Resection Without Hepatectomy

Volume–Outcome Associations after Major Hepatectomy for Hepatocellular Carcinoma: a Nationwide Taiwan Study

The Impact of Peri-operative Anti-TNF Treatment on Anastomosis-Related Complications in Crohn’s Disease Patients. A Critical Review

The Burden of Gastrointestinal Anastomotic Leaks: an Evaluation of Clinical and Economic Outcomes

Mid to Distal Small Bowel Resection with the Preservation of the Terminal Ileum Improves Glucose Homeostasis in Diabetic Rats by Activating the Hindgut-Dependent Mechanism